Design and quality control of large-scale two-sample Mendelian randomization studies
International Journal of Epidemiology · 05.10.2023 · 52 (5) · 1498-1521
DOI: 10.1093/ije/dyad018 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Epidemiology, online erschienen am 12.04.2023. Verfasst von Philip C Haycock und 28 weiteren Autor:innen. Beteiligte Einrichtung: MRC Integrative Epidemiology Unit (IEU), University of Bristol, Bristol, UK. Hauptthemen laut MEDLINE: Genome-Wide Association Study, Neoplasms. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 108 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust, Medical Research Council, World Health Organization.
Abstract (Originalsprache)
Background
Mendelian randomization (MR) studies are susceptible to metadata errors (e.g. incorrect specification of the effect allele column) and other analytical issues that can introduce substantial bias into analyses. We developed a quality control (QC) pipeline for the Fatty Acids in Cancer Mendelian Randomization Collaboration (FAMRC) that can be used to identify and correct for such errors.
Methods
We collated summary association statistics from fatty acid and cancer genome-wide association studies (GWAS) and subjected the collated data to a comprehensive QC pipeline. We identified metadata errors through comparison of study-specific statistics to external reference data sets (the National Human Genome Research Institute-European Bioinformatics Institute GWAS catalogue and 1000 genome super populations) and other analytical issues through comparison of reported to expected genetic effect sizes. Comparisons were based on three sets of genetic variants: (i) GWAS hits for fatty acids, (ii) GWAS hits for cancer and (iii) a 1000 genomes reference set.
Results
We collated summary data from 6 fatty acid and 54 cancer GWAS. Metadata errors and analytical issues with the potential to introduce substantial bias were identified in seven studies (11.6%). After resolving metadata errors and analytical issues, we created a data set of 219 842 genetic associations with 90 cancer types, generated in analyses of 566 665 cancer cases and 1 622 374 controls.
Conclusions
In this large MR collaboration, 11.6% of included studies were affected by a substantial metadata error or analytical issue. By increasing the integrity of collated summary data prior to their analysis, our protocol can be used to increase the reliability of downstream MR analyses. Our pipeline is available to other researchers via the CheckSumStats package (https://github.com/MRCIEU/CheckSumStats).
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- MRC Integrative Epidemiology Unit (IEU), University of Bristol, Bristol, UK.
- Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.
- Department of Medicine, University of Washington, Seattle, WA, USA.
- MRC Biostatistics Unit, University of Cambridge, Cambridge, UK.
- Department of Paediatrics, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
- Khoo Teck Puat-National University Children's Medical Institute, National University Health System, Singapore, Singapore.
ORCID-Profile: Philip C Haycock, Kimberley Burrows, Sean Harrison, Xuling Chang, Jie Zheng, Matthew H Law, Brenda M Birmann, Daniela Mariosa, Wei Zheng, George Davey Smith
Förderung
- Wellcome Trust
- Medical Research Council
- World Health Organization
- Cancer Research UK
- NCI NIH HHS
- Integrative Cancer Epidemiology Programme
- National Institute for Health Research
- Biomedical Research Centre at University Hospitals Bristol
Zitieren
APA
Haycock, P. C., Borges, M. C., Burrows, K., Lemaitre, R. N., Harrison, S., Burgess, S., Chang, X., Westra, J., Khankari, N. K., Tsilidis, K. K., Gaunt, T., Hemani, G., Zheng, J., Truong, T., O'Mara, T. A., Spurdle, A. B., Law, M. H., Slager, S. L., Birmann, B. M., …, & Fatty Acids in Cancer Mendelian Randomization Collaboration (2023). Design and quality control of large-scale two-sample Mendelian randomization studies. International Journal of Epidemiology, 52(5), 1498-1521. https://doi.org/10.1093/ije/dyad018
Vancouver
Haycock PC, Borges MC, Burrows K, Lemaitre RN, Harrison S, Burgess S, et al. Design and quality control of large-scale two-sample Mendelian randomization studies. International Journal of Epidemiology. 2023;52(5):1498-1521. doi:10.1093/ije/dyad018
BibTeX
@article{Haycock2023,
author = {Haycock, Philip C and Borges, Maria Carolina and Burrows, Kimberley and Lemaitre, Rozenn N and Harrison, Sean and Burgess, Stephen and Chang, Xuling and Westra, Jason and Khankari, Nikhil K and Tsilidis, Kostas K and Gaunt, Tom and Hemani, Gibran and Zheng, Jie and Truong, Therese and O'Mara, Tracy A and Spurdle, Amanda B and Law, Matthew H and Slager, Susan L and Birmann, Brenda M and Saberi Hosnijeh, Fatemeh and Mariosa, Daniela and Amos, Christopher I and Hung, Rayjean J and Zheng, Wei and Gunter, Marc J and Davey Smith, George and Relton, Caroline and Martin, Richard M and Fatty Acids in Cancer Mendelian Randomization Collaboration, Fatty Acids in Cancer Mendelian Randomization Collaboration},
title = {Design and quality control of large-scale two-sample Mendelian randomization studies},
journal = {International Journal of Epidemiology},
year = {2023},
volume = {52},
number = {5},
pages = {1498--1521},
doi = {10.1093/ije/dyad018}
}
EUVIMED